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Résumé en
anglais
Colorectal cancer (CRC) is a major cause of cancer-related death of worldwide with
high incidence and mortality rate, accessible to a screening program in France, first
with guaiac- based fecal occult blood test (g-FOBT) then with fecal immunochemical
tests (FIT), since 2015, because of better accuracy. The aim of our study was to
compare the characteristics of screen-detected lesions in two successive CRC
screening campaigns, using two different tests (Hemoccult II and OC Sensor) in the
department of Maine-et-Loire, and to precise the performance of these tests
[participation rate, detection rates (DR), positive predictive value (PPV)]. Participants,
invited by CAP SANTE 49, with polyps or cancer at the colonoscopy after a positive
screening test between 01/01/2013 and 31/12/2016 were included. A guaiac-based
fecal occult blood test (g-FOBT) was used from January 2013 to December 2014 and a
FIT was used from June 2015 to December 2016). 2575 participants, 642 in g-FOBT
group and 1933 in FIT group had lesions. Participation rate was not different between
tests (p = 0.104), whereas DR and PPV were statistically higher in FIT for all lesions
(2.61, 95% CI [2.50-2.70] vs 0.93, 95% CI [0.90-1.00], p < 0.0001 and 64.84, 95% CI
[63.10-66.60], 50.00, 95% CI [47.30-52.70], p < 0.0001 respectively). FIT detects
more precancerous lesions (adenomas, p < 0.001, and advanced adenomas, p < 0.001)
than g-FOBT but g-FOBT detects more serrated polyps (p = 0.025). AAs were more in
right colon in FIT than g-FOBT (p = 0.035). No different participation rate was
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